Oxurion NV (Germany) Top Insiders
| TG4 Stock | EUR 0.28 0.00 0.00% |
Oxurion NV employs about 34 people. The company is managed by 6 executives with a total tenure of roughly 80 years, averaging almost 13.0 years of service per executive, having 5.67 employees per reported executive. Examination of Oxurion NV's management performance can provide insight into the company performance.
| MD MBA Insider Chief Officer |
| Kathleen Paisley Insider Chief Officer |
Oxurion |
Oxurion NV Management Team Effectiveness
The company has return on total asset (ROA) of (1.0084) % which means that it has lost $1.0084 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (6.9415) %, meaning that it generated substantial loss on money invested by shareholders. Oxurion NV's management efficiency ratios could be used to measure how well Oxurion NV manages its routine affairs as well as how well it operates its assets and liabilities.Oxurion NV Workforce Comparison
Oxurion NV is currently regarded as top stock in number of employees category among its peers. The total workforce of Biotechnology industry is at this time estimated at about 46,100. Oxurion NV adds roughly 34.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.
Oxurion NV Notable Stakeholders
An Oxurion NV stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Oxurion NV often face trade-offs trying to please all of them. Oxurion NV's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Oxurion NV's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| MD MBA | Chief Officer | Profile | |
| Kathleen Paisley | Chief Officer | Profile | |
| Thomas CFA | CFO CEO | Profile | |
| Julie Binon | Chief Officer | Profile | |
| Wouter Piepers | Global Relations | Profile | |
| Michael Dillen | Chief Sec | Profile |
About Oxurion NV Management Performance
The success or failure of an entity such as Oxurion NV often depends on how effective the management is. Oxurion NV management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Oxurion management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Oxurion management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Oxurion NV, an integrated biopharmaceutical company, develops and commercializes medicines that address unmet clinical needs in ophthalmology in Belgium and internationally. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium. ThromboGenics operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 78 people.
Oxurion NV Workforce Analysis
Traditionally, organizations such as Oxurion NV use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Oxurion NV within its industry.Oxurion NV Manpower Efficiency
Return on Oxurion NV Manpower
| Revenue Per Employee | 33.2K | |
| Revenue Per Executive | 188K | |
| Net Loss Per Employee | 857.6K | |
| Net Loss Per Executive | 4.9M |
Complementary Tools for Oxurion Stock analysis
When running Oxurion NV's price analysis, check to measure Oxurion NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oxurion NV is operating at the current time. Most of Oxurion NV's value examination focuses on studying past and present price action to predict the probability of Oxurion NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oxurion NV's price. Additionally, you may evaluate how the addition of Oxurion NV to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Stocks Directory Find actively traded stocks across global markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |